The Dow Jones index closed higher by around 0.2% on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.
MariaDB
- The Trade: MariaDB plc MRDB 10% owner Investment Management, LLC bought a total of 7,803,747 shares at an average price of $0.55. To acquire these shares, it cost around $4.3 million.
- What's Happening: On May 15, MariaDB posted a second-quarter loss of 5 cents per share.
- What MariaDB Does: MariaDB plc, headquartered in Redwood City, California, operates as a cloud database company in North and South America, Europe, the Middle East, Africa, and the Asia Pacific.
Sypris Solutions
- The Trade: Sypris Solutions, Inc. SYPR Director Gary L Convis acquired a total of 5,615 shares at an average price of $1.58. To acquire these shares, it cost around $8,884.
- What's Happening: On Aug. 13, Sypris Solutions posted a decline in quarterly sales.
- What Sypris Solutions Does: Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics.
CPI Aerostructures
- The Trade: CPI Aerostructures, Inc. CVU Director Richard S Caswell acquired a total of 10,000 shares at an average price of $2.88. The insider spent around $28,800 to buy those shares.
- What's Happening: On Aug. 20, CPI Aerostructures named Philip Passarello as CFO.
- What CPI Aerostructures Does: CPI Aerostructures Inc is engaged in the manufacturing of structural aircraft parts for fixed-wing aircraft and helicopters in both the commercial and defense markets in the United States.
Standard BioTools
- The Trade: Standard BioTools Inc. LAB 10% owner Casdin Private Growth Equity Fund, L.P. acquired a total of 750,000 shares at an average price of $2.09. The insider spent around $1.5 million to buy those shares.
- What's Happening: On July 31, Standard BioTools reported worse-than-expected quarterly financial results and cut FY24 revenue guidance below estimates.
- What Standard BioTools Does: Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster.
Read More:
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in